[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enlivex Ltd (ENLV)

Enlivex Ltd (ENLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,703
  • Shares Outstanding, K 17,485
  • Annual Sales, $ 0 K
  • Annual Income, $ 1,236 M
  • EBIT $ -15 M
  • EBITDA $ -15 M
  • 60-Month Beta 1.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.31
  • Number of Estimates 1
  • High Estimate $-0.31
  • Low Estimate $-0.31
  • Prior Year $-1.20
  • Growth Rate Est. (year over year) +74.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3900 +5.76%
on 08/21/26
4.8300 -69.57%
on 07/22/26
-3.2600 (-68.92%)
since 07/21/26
3-Month
1.3900 +5.76%
on 08/21/26
13.4910 -89.10%
on 06/02/26
-9.3330 (-86.39%)
since 05/21/26
52-Week
1.3900 +5.76%
on 08/21/26
27.1500 -94.59%
on 11/24/25
-13.9800 (-90.49%)
since 08/21/25

Most Recent Stories

More News
Housing, Employment Numbers Featured in Short Week in U.S.

Monday U.S. U.S. Markets closed for Memorial Day Tuesday U.S. Economic Lookahead ...

PDD : 88.38 (-1.27%)
COST : 947.74 (+1.52%)
GCO : 35.07 (+2.69%)
ENLV : 1.4700 (-2.00%)
ADSK : 253.82 (+1.12%)
AZO : 2,957.95 (-0.14%)
ESLT : 741.33 (-0.31%)
SNPS : 397.87 (-0.01%)
CHA : 10.81 (+1.79%)
DELL : 442.08 (+1.68%)
CRM : 209.17 (+1.82%)
MRVL : 237.04 (-5.57%)
Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / March 20, 2026 / RedChip Companies will air interviews with Off The Hook YS Inc. (NYSE American:OTH) and Enlivex Ltd. (NASDAQ:ENLV) on the RedChip Small Stocks, Big Money™...

OTH : 2.57 (+2.19%)
ENLV : 1.4700 (-2.00%)
RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance

ORLANDO, FL / ACCESS Newswire / February 9, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced that on-demand...

MMA : 0.4600 (-18.76%)
ENLV : 1.4700 (-2.00%)
BGL : 0.2030 (+0.45%)
OWLS : 5.63 (+0.18%)
IPST : 9.65 (-6.40%)
RedChip Spotlights the Future of Finance at Fintech & Digital Asset Treasury Strategy (DATS) Virtual Investor Conference on February 4

ORLANDO, FLORIDA / ACCESS Newswire / January 27, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming...

MMA : 0.4600 (-18.76%)
ENLV : 1.4700 (-2.00%)
BGL : 0.2030 (+0.45%)
OWLS : 5.63 (+0.18%)
Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors

Enlivex Announced today $212,000,000 private placement to initiate world's first prediction markets digital asset treasury strategy, via RAIN token accumulation

ENLV : 1.4700 (-2.00%)
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / October 3, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Lantern Pharma, Inc. (Nasdaq:LTRN) on the RedChip Small Stocks,...

ENLV : 1.4700 (-2.00%)
LTRN : 2.34 (+2.18%)
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / September 19, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip...

ENLV : 1.4700 (-2.00%)
SXTP : 1.1300 (unch)
Home Sales Stateside, Canada GDP Due Next Week

Monday U.S. Economic Lookahead New home sales (July) Featured Earnings PDD ...

NVDA : 214.72 (-0.98%)
BEKE : 17.75 (+4.47%)
FRO : 43.67 (+0.25%)
CRWD : 191.95 (+0.85%)
SNOW : 332.78 (+3.58%)
ADSK : 253.82 (+1.12%)
MDB : 430.83 (+2.49%)
OKTA : 135.14 (+0.73%)
HEI : 355.04 (+1.27%)
NSSC : 38.09 (+0.85%)
JKS : 15.92 (+0.32%)
ENLV : 1.4700 (-2.00%)
Enlivex Therapeutics and Foremost Clean Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / June 13, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics (NASDAQ:ENLV) and Foremost Clean Energy (Nasdaq:FMST) on the RedChip Small Stocks, Big Money™...

ENLV : 1.4700 (-2.00%)
FMST : 1.2300 (+7.89%)
FAT.CN : 1.6600 (+6.41%)
RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis

Unlock AI-powered insights for data-driven precision and real-time efficiency

ENLV : 1.4700 (-2.00%)
ASPI : 4.00 (+1.27%)
BFRG : 0.5828 (+5.96%)
NVA : 5.36 (+3.28%)
GRRR : 16.06 (+5.31%)

Business Summary

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company principally in Israel. Its product pipeline includes the Allocetra which is in clinical trial. Enlivex Ltd., formerly known as Enlivex Therapeutics Ltd., is based in Ness Ziona, Israel....

See More

Key Turning Points

3rd Resistance Point 1.6600
2nd Resistance Point 1.5900
1st Resistance Point 1.5300
Last Price 1.4700
1st Support Level 1.4000
2nd Support Level 1.3300
3rd Support Level 1.2700

See More

52-Week High 27.1500
Fibonacci 61.8% 17.3097
Fibonacci 50% 14.2700
Fibonacci 38.2% 11.2303
Last Price 1.4700
52-Week Low 1.3900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.